# clm_A119CE234655

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 935,000,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2011-04-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_57CE22C1D3E7  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 935,000,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_A119CE234655, https://asof.is/claim/clm_A119CE234655, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-04-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-04-28)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 824,000,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_A119CE234655](/claim/clm_A119CE234655.md) | [clm_695BB0FA11F0](/claim/clm_695BB0FA11F0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.